Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$201,785,164
+$26,996,108 QoQ
Shares Held
3,598,808
-1.2% QoQ
Ownership
0.626%
of shares outstanding
% of Portfolio
6.70%
of 13F equity value
Holder Rank
#22
of 646 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Patient Capital Management, LLC holds $310,295,927 across 2 Biotechnology names. RPRX ranks #1 (65.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
3,598,808 | $201,785,164 | |
| 2 | PGEN |
Precigen, Inc.
|
19,036,976 | $108,510,763 |
All Filings in RPRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $201,785,164 | 3,598,808 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $174,789,056 | 3,643,716 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $128,813,202 | 3,333,675 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $109,997,748 | 3,117,850 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $107,657,207 | 2,987,988 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $92,538,469 | 2,972,646 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $73,343,520 | 2,875,089 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $57,745,406 | 2,041,195 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $37,561,164 | 1,424,390 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $43,119,872 | 1,419,818 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $35,246,770 | 1,254,780 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||